Ami Organics, a chemical research and development hub, is gearing up to seize the surging battery market with their memorandum of understanding (MoU) with a worldwide leader in electrolyte solutions is set to facilitate the establishment of battery cell and material manufacturing facilities within Gujarat’s borders.
Ami Organics Limited, founded under the Ami Group, is focused on transforming rational capital into specialty chemicals for Agrochemicals, Cosmetics, and Polymers. Their mission revolves around meeting diverse expectations, whether it’s offering a comprehensive portfolio of products, custom synthesis, or contract manufacturing for various projects. With a team of experienced and dedicated professionals, Ami organics operate production lines equipped with advanced testing facilities and the latest equipment. Their capabilities include providing New Chemical Entity (NCE) and large-scale supplies of pharma intermediates, positioning us as a key player in delivering pharmaceutical products adhering to GMP standards. Their fine and specialty chemicals meet ISO standards, and they are poised to expand our presence in the international market, fostering collaborations and future synergies with diverse organizations.
Ami Organics is intensifying its support for India’s “Make in India” campaign by committing a Rs 300 crore investment towards establishing a specialized electrolyte manufacturing facility. The official agreement is slated to occur during the upcoming Vibrant Gujarat Summit 2024, cementing Ami Organics’ dominant role in propelling the clean energy revolution. Naresh Patel, Executive Chairman and Managing Director, Ami Organics Limited, further comments, “It gives me immense pride to announce this landmark MoU, first for Ami Organics with a global manufacturer of electrolytes. We are privileged to build a long-term association as we collaborate with an illustrious name in the industry.”
Apart from their focus on batteries, Ami Organics excels in a wide array of specialty chemicals and advanced pharmaceutical ingredients. Boasting a portfolio of over 520 commercialized pharmaceutical intermediates, they wield significant influence in the healthcare sector as well. This Memorandum of Understanding signifies a pivotal moment for both Ami Organics and India’s rapidly expanding battery sector.
